Rs7528684
From SNPedia
| is a | snp |
| is | mentioned by |
| dbSNP | rs7528684 |
| hapmap | rs7528684 |
| hgdp | rs7528684 |
| ensembl | rs7528684 |
| gopubmed | rs7528684 |
| scholar | rs7528684 |
| rs7528684 | |
| pharmgkb | rs7528684 |
| hgvbaseg2p | rs7528684 |
| medrefsnp | rs7528684 |
| 23andMe | rs7528684 |
| SNP Nexus |
| Gene | FCRL3 |
| Chromosome | 1 |
| Orientation | plus |
| Position | 155937439 |
| Genotype | Effect |
|---|---|
| rs7528684(G;G) | 1.2x risk |
| rs7528684(A;G) | normal |
| rs7528684(A;A) | normal |
| Genotypes | Magnitude | Summary |
|---|---|---|
| Rs7528684(A;A) | 00 | normal |
| Rs7528684(A;G) | 00 | normal |
| Rs7528684(G;G) | 1.2x risk |
rs7528684 has been reported to be associated with rheumatoid arthritis in a Caucasian population, following reports of a similar association in a Japanese population. [PMID 16176992]
The risk allele (oriented to the dbSNP entry) is (G); the odds ratio associated with heterozygotes is 0.95 (CI 0.83-1.08), and for homozygotes, 2.30 (CI 1.64-3.23). [PMID 17179172]
In a study of 645 Caucasians from Southern Spain with multiple sclerosis, the rs7528684(G) allele (in dbSNP orientation) was found to be somewhat protective (per allele odds ratio 0.81, CI: 0.70-0.94, p=0.007).[PMID 18313765]
In another report [PMID 15838509], a summary indicates the following regarding disease and odds ratio (OR)for rs7528684:
- for rheumatoid arthritis: OR = 2.15 (CI = 1.58–2.93), from 830 cases and 658 controls;
- for SLE: OR = 1.49 (CI = 1.16–1.92), from 564 cases;
- for Graves' disease : OR = 1.79 (CI = 1.34–2.39), from 351 cases;
- for Hashimoto thyroiditis: OR = 1.62 (CI = 1.07–2.47), from 158 cases.
[PMID 18087673] rs7528684 rs3792876 and rs2268277 failed to showed a statistically significant association with rheumatoid arthritis
[PMID 18556175] rs7528684, rs11264799, rs945635 and rs3761959 were not associated with systemic lupus erythematosus (SLE) in a study of 248 Chinese Han patients.
| ? | (A;A) (A;G) (G;G) |
|---|---|
|
| |
[PMID 19438904] Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease